ReviewMolecular therapy oncolytics2022

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy.

Xinyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.